Publications, Reports & Books
The first edition of the BioPlan China Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in China, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in China as the country’s biopharmaceutical industry expands.
Our China Biopharmaceutical Index and our Top 60 Directory provide you information on trending of activities and changes occurring in the region. Be sure to keep up-to-date on Who’s Who in China. This report will help ensure you’re current, and have a solid understanding of this dynamic, rapidly changing market.
Author: Yibing (Eliza) Zhou
Published: BioPlan Associates, Inc., February 2008
By the Numbers:
- 305 pages
- Lists the key 123 Chinese-owned biopharmaceutical organizations
- 81 are recombinant and protein therapeutic biopharmaceutical companies
- Updated Quarterly